분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2011-05-12 14:57:18 , Hit : 2545
 HIV Drug Could Prevent Cervical Cancer, Researchers Discover

Science News
ScienceDaily (May 9, 2011) — A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists.

University of Manchester researchers, working with colleagues in Canada, have discovered how the antiviral drug lopinavir attacks HPV by switching on a natural viral defence system in infected cells.

The study, published in the journal Antiviral Therapy, builds on the team's previous work in 2006 that first identified lopinavir as a potential therapeutic for HPV-related cervical cancer following laboratory tests on cell cultures.

"Since publishing our earlier work, we have now found that lopinavir selectively kills HPV-infected, non-cancerous cells, while leaving healthy cells relatively unaffected," said Dr Ian Hampson, from Manchester's School of Cancer and Enabling Sciences.

"This is a very significant finding as these cells are not cancer cells but are the closest thing to being like the cells found in a pre-cancerous HPV infection of the cervix. In addition we were also able to show that lopinavir kills these HPV-infected cells by re-activating a well-known antiviral system that is suppressed by HPV."

In many developing countries, HPV-related cervical cancer is still one of the most common women's cancers accounting for approximately 290,000 deaths per year worldwide. The same virus also causes a significant proportion of cancers of the mouth and throat in both men and women and this disease is showing an alarming increase in developed countries, such as the UK, where it is now more than twice as common as cervical cancer.

Although in the developed world vaccination programmes against HPV are well underway, these are not effective in women already infected with HPV. Furthermore, the current vaccines do not protect against all types of HPV and they are expensive, which will limit their use in countries with limited resources. A cheap and preferably self-administered treatment that could eliminate early-stage HPV infections before these have developed into cancers would therefore have distinct health advantages.

Dr Hampson said: "Our results suggest that for this drug to work against HPV it would be necessary to treat virus-infected cells of the cervix with roughly 10-15 times the concentration that is normally found in HIV-infected patients taking lopinavir as tablets. This implies that, for this treatment to work, it would need to be locally applied as a cream or pessary."

Co-author on the paper, Dr Lynne Hampson, added: "These results are very exciting since they show that the drug not only preferentially kills HPV-infected non-cancerous cells by re-activating known antiviral defence systems, it is also much less toxic to normal non-HPV infected cells.

"Lopinavir is obviously safe for people to take as tablets or liquid but our latest findings provide very strong evidence to support a clinical trial using topical application of this drug to treat HPV infections of the cervix."

The research in Manchester was carried out by the Hampsons' PhD student, Gavin Batman, who was funded by the Humane Research Trust charity, with additional funding supplied by the Caring Cancer Trust and the Cancer Prevention Research Trust.

Email or share this story:| More
--------------------------------------------------------------------------------

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by University of Manchester, via AlphaGalileo.

--------------------------------------------------------------------------------

Journal Reference:

Gavin Batman, Anthony W Oliver, Ingeborg Zehbe, Christina Richard, Lynne Hampson, Ian N Hampson. Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells. Antiviral Therapy, 2011; DOI: 10.3851/IMP1786







907   Stem Cells of 10-Year-Old Help Create Blood Vessel in Life-Saving Surgery  이성욱 2011/05/11 2694
906   Foot-and-mouth culls could be cut  이성욱 2011/05/11 3202
  HIV Drug Could Prevent Cervical Cancer, Researchers Discover  이성욱 2011/05/12 2545
904   Liver repaired with stem cells taken from skin and blood  이성욱 2011/05/14 2409
903   Merck’s Hepatitis C Drug Wins F.D.A. Approval  이성욱 2011/05/17 2288
902   Setback for New Stem Cell Treatment  이성욱 2011/05/17 2100
901   Sugars recruited in fight against persistent infections  이성욱 2011/05/17 2961
900   The dark matter of disease -NC DNA  이성욱 2011/05/18 2575
899   Reprogrammed cells trigger immune reactions in mice  이성욱 2011/05/20 2159
898   Understanding HIV Latency to Undo It  이성욱 2011/05/23 2489
897   WHO to decide fate of smallpox stocks  이성욱 2011/05/24 2495
896   Vertex hepatitis C drug OK'd, promising more cures  이성욱 2011/05/25 2371
895   Stem cells: The growing pains of pluripotency  이성욱 2011/05/25 2136
894   Hepatitis C mouse model a major milestone  이성욱 2011/06/11 2166
893   Vertex licenses Hep C candidates in milestone-heavy deal  이성욱 2011/06/14 2876
892   Protein synthesis: Stop the nonsense  이성욱 2011/06/20 2329
891   HIV study reveals double jeopardy  이성욱 2011/06/26 2685
890   NIH's Secondhand Shop for Tried-and-Tested Drugs  이성욱 2011/06/27 2400
889   RNAs Regulate Cell Death  이성욱 2011/07/07 2565
888   South Korea back in stem cell spotlight with new treatment  이성욱 2011/07/08 2189

[이전 10개] [1]..[11][12][13][14][15][16][17][18] 19 [20]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN